외국약가참조제도의 국제적 동향

• 영문명: International Trend of External Reference Pricing
• 발행기관: 한국보건사회약료경영학회
• 저자명: 강대원(Dae-Won Kang) 배은미(Eun-Mi Bae) 신경선(Gyeong-Seon Shin) 임재옥(Jae-Ok Lim) 김성옥(Seong Ok Kim) 임재영(Jae Young Lim) 최상은(Sang-Eun Choi)
• 간행물 정보: 『한국보건사회약료경영학회지』제5권 제1호, 9~15쪽, 전체 7쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2016.12.30

영문 초록

BACKGROUND External reference pricing is widely used throughout the world due to its simplicity in pharmaceutical price setting and its cost-lowering effect. Korean government has been using external reference pricing process to set maximum prices for new drugs. Its importance was increased due to recently introduced policy where certain drugs can be exempted from economic evaluation and foreign prices are the only criteria for setting price. This study was conducted to review global trend of external reference pricing and gain insights about this process. METHODS We reviewed literatures about external reference pricing and different methodologies used in different countries. Theoretical and practical aspects of external reference pricing were reviewed and discussed. RESULTS External reference pricing was being used in 26 countries out of 28 European Union member countries. Many countries from other parts of the world, such as Canada, Mexico, Japan, Taiwan and Norway are using this process and the number of countries implementing this process is increasing. Although the main idea was the same, details varied between countries depending on their economic background. It is mostly used to regulate pharmaceutical prices and several studies suggested that it leads to lower prices. However, it is worried to cause a global price convergence and pharmaceutical companies can strategically use this to maximize profit. CONCLUSIONS Policy decision makers should be aware of the various external reference pricing carefully and flexibly according to their policy directions.

목차

서 론

연구방법

연구결과

고 찰

결 론

참고문헌

키워드

external reference pricing health policy pharmaceutical pricing